Tactile Systems Technology Inc (TCMD) Shares Up 3.9%
Tactile Systems Technology Inc (NASDAQ:TCMD)’s share price shot up 3.9% during mid-day trading on Thursday . The stock traded as high as $15.41 and last traded at $15.10, with a volume of 90,951 shares. The stock had previously closed at $14.53.
Several brokerages have issued reports on TCMD. Canaccord Genuity began coverage on Tactile Systems Technology in a report on Thursday, August 25th. They set a “buy” rating and a $21.00 price objective on the stock. BTIG Research started coverage on Tactile Systems Technology in a report on Monday, August 22nd. They set a “buy” rating and a $18.00 price target on the stock. William Blair started coverage on Tactile Systems Technology in a report on Monday, August 22nd. They set an “outperform” rating on the stock. Finally, Piper Jaffray Cos. started coverage on Tactile Systems Technology in a report on Monday, August 22nd. They set an “overweight” rating and a $17.00 price target on the stock.
The company’s market cap is $51.28 million. The stock has a 50-day moving average price of $13.39 and a 200-day moving average price of $13.39.
In other news, Director Peter H. Soderberg acquired 100,000 shares of the business’s stock in a transaction on Tuesday, August 2nd. The shares were purchased at an average price of $10.00 per share, for a total transaction of $1,000,000.00. Following the acquisition, the director now directly owns 5,000 shares of the company’s stock, valued at approximately $50,000. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.
Tactile Systems Technology, Inc is a medical technology company. The Company develops and provides medical devices for the treatment of chronic diseases at home. The Company focuses on advancing the standard of care in treating chronic diseases in the home setting to improve patient outcomes and quality of life and help control rising healthcare expenditures.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.